95% CI, 0.43-0.86). When venous and
prosthetic bypasses were analyzed separately, there was no
improvement in 12-month patency in patients undergoing
venous bypass who received acetylsalicylic acid (ASA) or
dipyridamole compared with placebo. Conversely, 12month primary patency was markedly improved in patients
undergoing prosthetic bypass who received ASA compared
with